dc.creatorCRESTANI, C. C.
dc.creatorALVES, F. H. F.
dc.creatorRESSTEL, L. B.
dc.creatorCORREA, F. M. A.
dc.date.accessioned2012-10-19T22:52:18Z
dc.date.accessioned2018-07-04T15:16:51Z
dc.date.available2012-10-19T22:52:18Z
dc.date.available2018-07-04T15:16:51Z
dc.date.created2012-10-19T22:52:18Z
dc.date.issued2008
dc.identifierBRITISH JOURNAL OF PHARMACOLOGY, v.153, n.3, p.583-590, 2008
dc.identifier0007-1188
dc.identifierhttp://producao.usp.br/handle/BDPI/24272
dc.identifier10.1038/sj.bjp.0707591
dc.identifierhttp://dx.doi.org/10.1038/sj.bjp.0707591
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1621000
dc.description.abstractBackground and purpose: We have previously shown that noradrenaline microinjected into the bed nucleus of stria terminalis (BST) elicited pressor and bradycardiac responses in unanaesthetized rats. In the present study, we investigated the subtype of adrenoceptors that mediates the cardiovascular response to noradrenaline microinjection into the BST. Experimental approach: Cardiovascular responses following noradrenaline microinjection into the BST of male Wistar rats were studied before and after BST pretreatment with different doses of the selective alpha(1)-adrenoceptor antagonist WB4101, the alpha(2)-adrenoceptor antagonist RX821002, the combination of WB4101 and RX821002, the non-selective beta-adrenoceptor antagonist propranolol, the selective beta(1)-adrenoceptor antagonist CGP20712 or the selective beta(2)-adrenoceptor antagonist ICI118,551. Key results: Noradrenaline microinjected into the BST of unanaesthetized rats caused pressor and bradycardiac responses. Pretreatment of the BST with different doses of either WB4101 or RX821002 only partially reduced the response to noradrenaline. However, the response to noradrenaline was blocked when WB4101 and RX821002 were combined. Pretreatment with this combination also shifted the resulting dose-effect curve to the left, clearly showing a potentiating effect of this antagonist combination. Pretreatment with different doses of either propranolol or CGP20712 increased the cardiovascular responses to noradrenaline microinjected into the BST. Pretreatment with ICI118,551 did not affect cardiovascular responses to noradrenaline. Conclusion and implications: The present results indicate that alpha(1) and alpha(2)-adrenoceptors mediate the cardiovascular responses to noradrenaline microinjected into the BST. In addition, they point to an inhibitory role played by the activation of local beta(1)-adrenoceptors in the cardiovascular response to noradrenaline microinjected into the BST.
dc.languageeng
dc.publisherNATURE PUBLISHING GROUP
dc.relationBritish Journal of Pharmacology
dc.rightsCopyright NATURE PUBLISHING GROUP
dc.rightsrestrictedAccess
dc.subjectcardiovascular system
dc.subjectnoradrenaline
dc.subjectalpha-adrenoceptors
dc.subjectbeta-adrenoceptors
dc.titleBoth alpha 1 and alpha 2-adrenoceptors mediate the cardiovascular responses to noradrenaline microinjected into the bed nucleus of the stria terminal of rats
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución